A2-MHC corresponds to a peptide designed to interact with MHC class I A2 molecules. The sequence supports studies on epitope binding, anchor residue positioning, and presentation stability. Researchers employ it in structural immunology to probe antigen-MHC conformational dynamics. Its defined motif aids receptor-binding and docking studies.
CAT No: ta-041
A2-MHC, also known as HLA-A2 Major Histocompatibility Complex, is a peptide-MHC complex of significant importance in immunological and biochemical research. As a member of the human leukocyte antigen (HLA) class I family, A2-MHC presents antigenic peptides to cytotoxic T lymphocytes, playing a central role in cellular immune recognition. Its well-characterized peptide-binding groove and prevalence in human populations make it a valuable model for studying antigen presentation, immune surveillance, and T cell receptor (TCR) interactions. The biochemical stability and defined molecular structure of A2-MHC have positioned it as a critical reagent in both fundamental and translational studies within immunology and molecular biology.
Antigen Presentation Studies: The A2-MHC complex is widely utilized in research focused on the mechanisms of antigen processing and presentation. By reconstituting peptide-loaded MHC molecules in vitro, investigators can dissect the molecular determinants governing peptide binding specificity and stability. This enables a deeper understanding of how endogenous and exogenous peptides are selected and displayed on the cell surface, which is essential for elucidating immune recognition pathways and developing targeted immunotherapies.
T Cell Receptor Interaction Analysis: In studies of T cell activation and specificity, A2-MHC serves as a standardized platform for examining TCR-peptide-MHC interactions. Researchers employ soluble or immobilized forms of the complex to probe the affinity, kinetics, and structural basis of TCR engagement. Such analyses are crucial for mapping T cell repertoires, characterizing cross-reactivity, and informing the design of TCR-based assays or engineered T cell products for research use.
Epitope Mapping and Vaccine Research: The defined peptide-binding characteristics of A2-MHC make it an indispensable tool for epitope mapping and immunogenicity assessment. By presenting candidate peptides, the complex allows for the screening and validation of T cell epitopes derived from pathogens, tumor antigens, or neoantigens. This application supports the rational design of peptide-based vaccines and immunodiagnostic reagents, facilitating the identification of immune targets with high relevance to human populations.
Structural and Biophysical Characterization: The A2-MHC molecule is frequently employed in structural biology to elucidate the three-dimensional architecture of peptide-MHC-TCR complexes. Crystallographic and biophysical studies using this reagent have provided fundamental insights into the conformational dynamics, binding energetics, and allosteric regulation of immune recognition. These findings inform the broader understanding of MHC polymorphism and its implications for immune diversity.
Assay Development and Quality Control: A2-MHC complexes are integral to the development and validation of immunological assays, including ELISPOT, tetramer staining, and flow cytometry-based platforms. By providing a consistent and well-defined reagent for peptide presentation, the complex enhances the reproducibility and sensitivity of assays designed to detect antigen-specific T cell responses. This application underpins quality control protocols in research and biomanufacturing settings, supporting the reliable assessment of immune function in experimental systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More